Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘OneSource, the Group’s Spec Pharm CDMO, receives equity commitments of INR 8,010 mn (USD 95 mn) from marquee investors at a pre-money equity valuation of USD 1.65 bn.’
The above information is a part of company’s filings submitted to BSE.